mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-07 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-07 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-06 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-06 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |